Scottsdale, AZ, Jan. 17, 2023 (GLOBE NEWSWIRE) Stephen Bishop, MBA, MS, MLS (ASCP), CPHQ, a healthcare consultant at Accumen Inc., was named Certified.
A biopharmaceutical company and the Miller School of Medicine at the University of Miami have announced a partnership to conduct a phase 1/2a clinical trial of ALZN002, a treatment for Alzheimer’s-related dementia.According to a release from Alzamend Neuro, ALZN002 is a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and.